In vitro comparison of clindamycin and pirlimycin (U-57930E) activity against Staphylococcus aureus.
AUTOR(ES)
Evans, M E
RESUMO
The activities of clindamycin and its derivative, pirlimycin (U-57930E), were compared against 100 strains of Staphylococcus aureus, using a microtiter broth dilution technique. Minimal inhibitory concentrations demonstrated that pirlimycin was comparable to clindamycin but offered no increase in activity against either methicillin-susceptible or methicillin-resistant S. aureus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=183736Documentos Relacionados
- In vitro activity of pipecolic acid amide of clindamycin (U-57930E) on anaerobic bacteria compared with those of clindamycin, cefoxitin, and chloramphenicol.
- Activity of pirlimycin (U57930E) against strains of the Bacteroides fragilis group.
- In vitro activity of U-57930E, a new clindamycin analog, against aerobic gram-positive bacteria.
- Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus.
- In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
